Logo image of CHCI

COMSTOCK HOLDING COMPANIES (CHCI) Stock Fundamental Analysis

NASDAQ:CHCI - US2056842022 - Common Stock

15.945 USD
+0.92 (+6.09%)
Last: 8/25/2025, 8:10:32 PM
Fundamental Rating

7

CHCI gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. Both the health and profitability get an excellent rating, making CHCI a very profitable company, without any liquidiy or solvency issues. CHCI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year CHCI was profitable.
In the past year CHCI had a positive cash flow from operations.
Each year in the past 5 years CHCI has been profitable.
In the past 5 years CHCI always reported a positive cash flow from operatings.
CHCI Yearly Net Income VS EBIT VS OCF VS FCFCHCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

CHCI's Return On Assets of 24.12% is amongst the best of the industry. CHCI outperforms 100.00% of its industry peers.
CHCI has a Return On Equity of 28.38%. This is amongst the best in the industry. CHCI outperforms 100.00% of its industry peers.
CHCI has a Return On Invested Capital of 16.04%. This is amongst the best in the industry. CHCI outperforms 98.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHCI is significantly above the industry average of 5.46%.
Industry RankSector Rank
ROA 24.12%
ROE 28.38%
ROIC 16.04%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
CHCI Yearly ROA, ROE, ROICCHCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

Looking at the Profit Margin, with a value of 28.35%, CHCI belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
CHCI's Profit Margin has improved in the last couple of years.
CHCI has a better Operating Margin (20.59%) than 84.13% of its industry peers.
In the last couple of years the Operating Margin of CHCI has grown nicely.
CHCI has a Gross Margin (25.02%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CHCI has grown nicely.
Industry RankSector Rank
OM 20.59%
PM (TTM) 28.35%
GM 25.02%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
CHCI Yearly Profit, Operating, Gross MarginsCHCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

9

2. Health

2.1 Basic Checks

CHCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CHCI has more shares outstanding
The number of shares outstanding for CHCI has been increased compared to 5 years ago.
There is no outstanding debt for CHCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHCI Yearly Shares OutstandingCHCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CHCI Yearly Total Debt VS Total AssetsCHCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 8.14 indicates that CHCI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.14, CHCI belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
CHCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.14
ROIC/WACC1.8
WACC8.9%
CHCI Yearly LT Debt VS Equity VS FCFCHCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 4.26 indicates that CHCI has no problem at all paying its short term obligations.
CHCI has a Current ratio of 4.26. This is amongst the best in the industry. CHCI outperforms 82.54% of its industry peers.
CHCI has a Quick Ratio of 4.26. This indicates that CHCI is financially healthy and has no problem in meeting its short term obligations.
CHCI has a better Quick ratio (4.26) than 87.30% of its industry peers.
Industry RankSector Rank
Current Ratio 4.26
Quick Ratio 4.26
CHCI Yearly Current Assets VS Current LiabilitesCHCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.81% over the past year.
CHCI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 61.08% yearly.
CHCI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.35%.
CHCI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)82.81%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%50.98%
Revenue 1Y (TTM)18.35%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%20.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHCI Yearly Revenue VS EstimatesCHCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.56, the valuation of CHCI can be described as reasonable.
Based on the Price/Earnings ratio, CHCI is valued cheaply inside the industry as 92.06% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.03. CHCI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.56
Fwd PE N/A
CHCI Price Earnings VS Forward Price EarningsCHCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CHCI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHCI is cheaper than 93.65% of the companies in the same industry.
CHCI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CHCI is cheaper than 92.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.43
EV/EBITDA 10.29
CHCI Per share dataCHCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CHCI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COMSTOCK HOLDING COMPANIES

NASDAQ:CHCI (8/25/2025, 8:10:32 PM)

15.945

+0.92 (+6.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-05 2025-11-05
Inst Owners7.39%
Inst Owner Change16.3%
Ins Owners66.41%
Ins Owner Change-1.71%
Market Cap160.57M
Analysts0
Price TargetN/A
Short Float %0.69%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.56
Fwd PE N/A
P/S 2.89
P/FCF 11.43
P/OCF 11.14
P/B 2.9
P/tB 2.9
EV/EBITDA 10.29
EPS(TTM)1.51
EY9.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.39
FCFY8.75%
OCF(TTM)1.43
OCFY8.97%
SpS5.51
BVpS5.51
TBVpS5.49
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 24.12%
ROE 28.38%
ROCE 20.3%
ROIC 16.04%
ROICexc 34.98%
ROICexgc 35.24%
OM 20.59%
PM (TTM) 28.35%
GM 25.02%
FCFM 25.3%
ROA(3y)20.05%
ROA(5y)19.74%
ROE(3y)27.08%
ROE(5y)30.75%
ROIC(3y)18.89%
ROIC(5y)16.39%
ROICexc(3y)36.53%
ROICexc(5y)31.24%
ROICexgc(3y)36.83%
ROICexgc(5y)32.34%
ROCE(3y)23.91%
ROCE(5y)20.74%
ROICexcg growth 3Y10.99%
ROICexcg growth 5Y13.58%
ROICexc growth 3Y10.68%
ROICexc growth 5Y17.17%
OM growth 3Y6.94%
OM growth 5Y17.14%
PM growth 3Y-13.42%
PM growth 5Y51.49%
GM growth 3Y6.26%
GM growth 5Y8.78%
F-Score5
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 113.79%
Cap/Sales 0.65%
Interest Coverage 250
Cash Conversion 122.64%
Profit Quality 89.24%
Current Ratio 4.26
Quick Ratio 4.26
Altman-Z 8.14
F-Score5
WACC8.9%
ROIC/WACC1.8
Cap/Depr(3y)179.46%
Cap/Depr(5y)167.67%
Cap/Sales(3y)0.93%
Cap/Sales(5y)0.78%
Profit Quality(3y)87.69%
Profit Quality(5y)95.22%
High Growth Momentum
Growth
EPS 1Y (TTM)82.81%
EPS 3Y-1.83%
EPS 5Y61.08%
EPS Q2Q%50.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.35%
Revenue growth 3Y18.15%
Revenue growth 5Y15.18%
Sales Q2Q%20.64%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.82%
EBIT growth 3Y26.35%
EBIT growth 5Y34.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.55%
FCF growth 3Y10.69%
FCF growth 5Y4.68%
OCF growth 1Y121.68%
OCF growth 3Y11.03%
OCF growth 5Y4.91%